Dr. Javeria Bhawal, MD

Dr. Bhawal practices at Labcorp - Birmingham (1st Ave S) in Birmingham, Alabama.

Dr. Bhawal's NPI, 1285076893, was assigned on July 24, 2013. Dr. Bhawal graduated from Other in 2004. Dr. Bhawal's Mississippi license number on file is 74143.

Dr. Bhawal's primary practice is Labcorp - Birmingham (1st Ave S), at 1801 First Ave South, Birmingham, AL 35233. The practice phone is (205) 581-3500.

Dr. Bhawal's primary practice is Labcorp - Birmingham (1st Ave S) in Birmingham, Alabama. Dr. Bhawal is also affiliated with Wellstar Kennestone Regional Medical Center. The medical group on file is Select Physical Therapy. Dmand AI also links Dr. Bhawal to 5 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhawal practices, 8 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Bhawal's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Bhawal is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Bhawal's licenses on file in 2 states: Mississippi and Georgia.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, fluid in a joint, gout, joint arthropathy, joint pain and lupus among the conditions Dr. Bhawal treats.

CMS data shows 10,690 Medicare services from Dr. Bhawal across 30 procedure codes in 2024, for 304 Medicare patients. Medicare paid $280,362 for them. Every service was in an office.

CMS counts 304 Medicare patients who saw Dr. Bhawal in 2024. The largest group is 65 to 74, with 155 patients. 75% of them have arthritis, and 75% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bhawal's median patient age at 56, with 78% women.

In 2024, Dr. Bhawal wrote 2,812 Medicare Part D claims for 434 patients. 93% of them were for generic drugs. CMS names the drug for 2,496 of them, across 37 drugs with 11 or more claims each, at $216,509 in total drug cost. In 2023, CMS named 2,214 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Bhawal for performance year 2024, reported individually. Dr. Bhawal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bhawal as offering telehealth.

Dmand AI links 1 paper to Dr. Bhawal in 2020. Dr. Bhawal's most frequent co-authors are Alexander C. Barnes, MD and Joseph Stephen Christiansen, MD.

CMS Open Payments shows 556 general payments to Dr. Bhawal from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. UCB, Inc. paid the most, $2,031.

Dr. Bhawal graduated from Other in 2004.

Dr. Bhawal is in network with 17 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.